All news from Anaesthesiology

Detection Of AD Are The Concentrations Of Beta-Amyloid And Phosphorylated Tau

Researcher used biomarkers for the early detection of Alzheimer's disease (AD) are currently the concentrations of beta-amyloid and phosphorylated Tau in cerebrospinal fluid. However, it has been observed that not all individuals with alterations in these biomarkers develop the disease. In this regard, intense research efforts are being channeled into finding new biological markers that can provide information about the different stages of the disease and allow its early detection, and thus facilitate its management. The study was published in Analytical Chemistry.